Senior Director, MASH/ALD Brand & Pipeline Strategy

GlaxoSmithKline; Chicago (IL); On-site; USD 205,000 - 341,000; Full time

Job summary

GlaxoSmithKline seeks a Sr. Director to lead MASH/ALD brand strategy and the US Hepatology/Immunology pipeline governance from development to launch readiness.

You will shape the commercial vision, align cross-functional teams, and drive lifecycle planning to maximize patient impact. The role requires leadership across brand strategy, pricing and access, and early commercialization, with close collaboration to Medical Affairs, Market Access, and Finance to ensure a robust value proposition for

Qualifications

• Bachelor's degree is required (Marketing, Business, Life Sciences, or related field).
• Minimum 10 years of pharmaceutical/healthcare experience with Hepatology/Immunology exposure.
• In-line brand marketing or brand management experience with launch planning.

Responsibilities

• Own U.S. pipeline and portfolio strategy for Hepatology/Immunology assets.
• Define market analyses and commercial assumptions with cross-functional partners.
• Lead stage-gate inputs and represent U.S. perspective in governance forums.
• Build the pre-launch commercial foundation including TPP, positioning, and segmentation.
• Collaborate with Sales, Medical, Market Access, and Finance to align priorities.
• Manage budget and resources for pipeline-related activities.

Skills

Data to Insights

Digital Fluency

Marketing Campaign Planning

Marketing Measurement

Marketing Strategy Implementation

Omnichannel Marketing

Scientific Literacy

Job description

GlaxoSmithKline seeks a Sr. Director to lead MASH/ALD brand strategy and the US Hepatology/Immunology pipeline governance from development to launch readiness.

You will shape the commercial vision, align cross-functional teams, and drive lifecycle planning to maximize patient impact. The role requires leadership across brand strategy, pricing and access, and early commercialization, with close collaboration to Medical Affairs, Market Access, and Finance to ensure a robust value proposition for